HCA Healthcare Inc (NYSE:HCA) insider Charles J. Hall sold 35,949 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $103.09, for a total transaction of $3,705,982.41. Following the completion of the sale, the insider now owns 111,237 shares in the company, valued at approximately $11,467,422.33. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
HCA Healthcare Inc (NYSE HCA) traded up $1.91 on Friday, reaching $97.84. 2,530,000 shares of the company’s stock were exchanged, compared to its average volume of 2,450,000. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58. The stock has a market capitalization of $35,340.00, a PE ratio of 16.47, a price-to-earnings-growth ratio of 0.98 and a beta of 0.48. HCA Healthcare Inc has a 52-week low of $71.18 and a 52-week high of $106.84.
HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.87 by $0.25. The firm had revenue of $11.56 billion for the quarter, compared to analysts’ expectations of $11.19 billion. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.80 earnings per share. sell-side analysts expect that HCA Healthcare Inc will post 8.71 EPS for the current year.
A number of equities analysts have recently commented on the stock. Morgan Stanley lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $85.00 price target on the stock. in a report on Wednesday, December 20th. Credit Suisse Group restated an “outperform” rating and issued a $25.00 target price on shares of HCA Healthcare in a report on Tuesday, December 26th. Bank of America lowered shares of HCA Healthcare from a “neutral” rating to an “underperform” rating and dropped their target price for the company from $94.00 to $90.00 in a report on Thursday, January 4th. Robert W. Baird set a $104.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a report on Friday, January 12th. Finally, Citigroup raised shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and eighteen have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $103.65.
Institutional investors have recently bought and sold shares of the stock. Atlantic Trust LLC bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $118,000. BB&T Investment Services Inc. bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $141,000. D.A. Davidson & CO. increased its holdings in HCA Healthcare by 37.7% during the 2nd quarter. D.A. Davidson & CO. now owns 1,970 shares of the company’s stock worth $171,000 after acquiring an additional 539 shares during the period. Bronfman E.L. Rothschild L.P. increased its holdings in shares of HCA Healthcare by 108.0% in the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock worth $213,000 after buying an additional 1,259 shares during the last quarter. Finally, Kovack Advisors Inc. bought a new position in shares of HCA Healthcare in the 4th quarter worth $234,000. 74.89% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://stocknewstimes.com/2018/02/11/charles-j-hall-sells-35949-shares-of-hca-healthcare-inc-hca-stock.html.
HCA Healthcare Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.